Detailed Information on Publication Record
2021
Long-QT founder variant T309I-Kv7.1 with dominant negative pattern may predispose delayed afterdepolarizations under β-adrenergic stimulation
SYNKOVÁ, Iva, Markéta BÉBAROVÁ, Irena ANDRŠOVÁ, Larisa CHMELIKOVA, Olga ŠVECOVÁ et. al.Basic information
Original name
Long-QT founder variant T309I-Kv7.1 with dominant negative pattern may predispose delayed afterdepolarizations under β-adrenergic stimulation
Authors
SYNKOVÁ, Iva (203 Czech Republic, belonging to the institution), Markéta BÉBAROVÁ (203 Czech Republic, guarantor, belonging to the institution), Irena ANDRŠOVÁ (203 Czech Republic, belonging to the institution), Larisa CHMELIKOVA (203 Czech Republic), Olga ŠVECOVÁ (203 Czech Republic, belonging to the institution), Jan HOSEK (203 Czech Republic), Michal PÁSEK (203 Czech Republic, belonging to the institution), Pavel VÍT (203 Czech Republic, belonging to the institution), Iveta VALÁŠKOVÁ (203 Czech Republic, belonging to the institution), Renata GAILLYOVÁ (203 Czech Republic, belonging to the institution), Rostislav NAVRATIL (203 Czech Republic) and Tomáš NOVOTNÝ (203 Czech Republic, belonging to the institution)
Edition
Nature Scientific Reports, London, NATURE RESEARCH, 2021, 2045-2322
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
30101 Human genetics
Country of publisher
Germany
Confidentiality degree
není předmětem státního či obchodního tajemství
References:
Impact factor
Impact factor: 4.996
RIV identification code
RIV/00216224:14110/21:00120095
Organization unit
Faculty of Medicine
UT WoS
000626725200007
Keywords in English
Long-QT founder variant T309I-Kv7.1; afterdepolarizations; β-adrenergic stimulation
Tags
International impact, Reviewed
Změněno: 16/5/2022 08:52, Mgr. Tereza Miškechová
Abstract
V originále
The variant c.926C > T (p.T309I) in KCNQ1 gene was identified in 10 putatively unrelated Czech families with long QT syndrome (LQTS). Mutation carriers (24 heterozygous individuals) were more symptomatic compared to their non-affected relatives (17 individuals). The carriers showed a mild LQTS phenotype including a longer QTc interval at rest (466 ± 24 ms vs. 418 ± 20 ms) and after exercise (508 ± 32 ms vs. 417 ± 24 ms), 4 syncopes and 2 aborted cardiac arrests. The same haplotype associated with the c.926C > T variant was identified in all probands. Using the whole cell patch clamp technique and confocal microscopy, a complete loss of channel function was revealed in the homozygous setting, caused by an impaired channel trafficking. Dominant negativity with preserved reactivity to β-adrenergic stimulation was apparent in the heterozygous setting. In simulations on a human ventricular cell model, the dysfunction resulted in delayed afterdepolarizations (DADs) and premature action potentials under β-adrenergic stimulation that could be prevented by a slight inhibition of calcium current. We conclude that the KCNQ1 variant c.926C > T is the first identified LQTS-related founder mutation in Central Europe. The dominant negative channel dysfunction may lead to DADs under β-adrenergic stimulation. Inhibition of calcium current could be possible therapeutic strategy in LQTS1 patients refractory to β-blocker therapy.
Links
NV16-30571A, research and development project |
|